£124k
+50%vs Mar 2024Active11881013Private limited companySouthampton
B&M CELLULAR PATHOLOGY LIMITED
Significant control: Balvinder Singh Shoker (50–75%), Manjit Kaur Shoker (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for B&M Cellular Pathology Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does B&M Cellular Pathology Limited sell?
Registered activity: Specialists medical practice activities (SIC 86220). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
B&M CELLULAR PATHOLOGY LIMITED is an active private limited company (company number 11881013) incorporated on 13 March 2019, registered in Southampton. Its registered activity is specialists medical practice activities (SIC 86220). Latest small accounts cover the period ending 31 March 2025, showing net assets of £124k and cash of £127k, with 1 employee on average. Net assets rose 50% on the prior period (£83k).
Peer position · net assets
By net assets it sits in the top quarter of 432 comparable companies in Southampton (median £35k, upper quartile £124k).
02
Ownership and control
- Mr Balvinder Singh Shoker
- owns 50–75% of shares
- holds 50–75% of voting rights
- can appoint or remove directors
- Mrs Manjit Kaur Shoker
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 13 March 20197 yrs ago
- Next accounts due
- 31 December 2026in 64 days
- Confirmation statement due
- 27 March 2027in 150 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 86220
- Specialists medical practice activities
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£127k
+34%vs Mar 2024Not reported
1
No changevs Mar 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £124k | £127k | £1,993 | — | — | — | 1 |
| 31 March 2024 | £83k | £94k | £1,379 | — | — | — | 1 |
Cash per employee£127kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £124,173 at 31 March 2025
- Net assets up 10% or more on the prior period+49.9% vs prior period
- Cash at bank of £50,000 or moreCash £126,684
- Incorporated five or more years agoIncorporated 13 March 2019
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 150 days
- Next accounts duein 64 days
- Accounts period endNet assets £124k · small accounts
- Accounts period endNet assets £83k · small accounts
- Incorporated
08
Similar companies in Southampton
- DORSET RADIOLOGIST LIMITEDRomsey · inc. Mar 2019
- T D UROLOGY LIMITEDRomsey · inc. Mar 2019
- TFG MEDICAL LIMITEDRomsey · inc. Mar 2019
- SOUTH COAST NEURORADIOLOGY LIMITEDSouthampton · inc. Mar 2019
- LONDON MEDICAL LIMITEDWinchester · inc. Mar 2019
- ELITE CARDIAC SCREENING LTDEastleigh · inc. Mar 2019
All companies incorporated on 13 March 2019 · in Mar 2019.
09
Reminders for B&M CELLULAR PATHOLOGY LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.